References

• 1999Characteristics of insomnia in the United States: results of the 1991 National Sleep Foundation Survey. I.776 cited
• 1997Prevalence, burden, and treatment of insomnia in primary care694 cited
• 2003Sustained Efficacy of Eszopiclone Over 6 Months of Nightly Treatment: Results of a Randomized, Double-Blind, Placebo-Controlled Study in Adults with Chronic Insomnia630 cited
• 2006Eszopiclone Co-Administered With Fluoxetine in Patients With Insomnia Coexisting With Major Depressive Disorder480 cited
• 2007The Direct and Indirect Costs of Untreated Insomnia in Adults in the United States403 cited
• 1999Daytime consequences and correlates of insomnia in the United States: results of the 1991 National Sleep Foundation Survey. II.397 cited
• 2004Efficacy and safety of eszopiclone across 6-weeks of treatment for primary insomnia294 cited
• 2007Nightly Treatment of Primary Insomnia With Eszopiclone for Six Months: Effect on Sleep, Quality of Life, and Work Limitations239 cited
• 2004Clinical and socioeconomic correlates of insomnia.234 cited
• 1994A multicenter, placebo-controlled study evaluating zolpidem in the treatment of chronic insomnia.223 cited
• 1999Insomnia in primary care patients.215 cited
• 2005An international survey of insomnia: under-recognition and under-treatment of a polysymptomatic condition207 cited
• 1998Insomnia, Health-Related Quality of Life and Healthcare Resource Consumption190 cited